Iain Bishop

1.1k total citations
12 papers, 395 citations indexed

About

Iain Bishop is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Iain Bishop has authored 12 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 4 papers in Geriatrics and Gerontology and 4 papers in Pharmacology. Recurrent topics in Iain Bishop's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Iain Bishop is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Iain Bishop collaborates with scholars based in United Kingdom, Sweden and Italy. Iain Bishop's co-authors include Brian Godman, Stephen Campbell, Marion Bennie, Lars L. Gustafsson, Alexander Finlayson, Hye-Young Kwon, Vera Vlahović–Palčevski, Luka Vončina, Thomas Burkhardt and Catherine Sermet and has published in prestigious journals such as Gut, Frontiers in Pharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

Iain Bishop

12 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iain Bishop United Kingdom 9 321 106 95 62 41 12 395
Kristina Garuolienė Lithuania 10 407 1.3× 94 0.9× 114 1.2× 46 0.7× 54 1.3× 16 516
Colleen Bush United States 7 152 0.5× 35 0.3× 57 0.6× 94 1.5× 54 1.3× 11 306
Jurij Fürst United Kingdom 10 161 0.5× 26 0.2× 55 0.6× 39 0.6× 53 1.3× 17 317
Inês Teixeira Portugal 10 151 0.5× 35 0.3× 44 0.5× 64 1.0× 44 1.1× 25 260
Cynthia Reilly United States 7 146 0.5× 31 0.3× 53 0.6× 51 0.8× 16 0.4× 11 265
Gin Nie Chua Malaysia 9 172 0.5× 47 0.4× 62 0.7× 42 0.7× 64 1.6× 26 308
Caijun Yang China 8 140 0.4× 18 0.2× 33 0.3× 35 0.6× 30 0.7× 20 289
Alvaro San-Juan-Rodriguez United States 8 156 0.5× 49 0.5× 48 0.5× 98 1.6× 39 1.0× 13 333
Christine Huttin France 10 187 0.6× 42 0.4× 29 0.3× 24 0.4× 74 1.8× 41 269
Sundus Shukar China 6 117 0.4× 16 0.2× 39 0.4× 41 0.7× 32 0.8× 14 251

Countries citing papers authored by Iain Bishop

Since Specialization
Citations

This map shows the geographic impact of Iain Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain Bishop more than expected).

Fields of papers citing papers by Iain Bishop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iain Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain Bishop. The network helps show where Iain Bishop may publish in the future.

Co-authorship network of co-authors of Iain Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Iain Bishop. A scholar is included among the top collaborators of Iain Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iain Bishop. Iain Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Moon, James, Brian Godman, Max Petzold, et al.. (2014). Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology. 5. 219–219. 37 indexed citations
2.
Godman, Brian, Iain Bishop, Stephen Campbell, Rickard E. Malmström, & Ilse Truter. (2014). Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications. Expert Review of Pharmacoeconomics & Outcomes Research. 15(2). 323–330. 8 indexed citations
3.
McTaggart, Stuart, et al.. (2014). PWE-176 Prevalence, Management, And Healthcare Burden Of Irritable Bowel Syndrome (ibs) In Scotland. Gut. 63(Suppl 1). A202.2–A203. 2 indexed citations
4.
Godman, Brian, Iain Bishop, Alexander Finlayson, et al.. (2013). Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research. 13(4). 469–482. 68 indexed citations
5.
Bennie, Marion, Iain Bishop, Brian Godman, et al.. (2013). Are prescribing initiatives readily transferable across classes: the case of generic losartan in Scotland?. PubMed. 21(1). 7–15. 18 indexed citations
6.
Bennie, Marion, Iain Bishop, Brian Godman, et al.. (2013). Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice. 67(2). 170–180. 13 indexed citations
7.
Bennie, Marion, Brian Godman, Iain Bishop, & Stephen Campbell. (2012). Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Review of Pharmacoeconomics & Outcomes Research. 12(1). 125–130. 73 indexed citations
8.
Godman, Brian, Björn Wettermark, Iain Bishop, et al.. (2012). European payer initiatives to reduce prescribing costs through use of generics. Generics and Biosimilars Initiative Journal. 1(1). 22–27. 37 indexed citations
9.
Vončina, Luka, Brian Godman, Marion Bennie, et al.. (2011). Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research. 11(4). 469–479. 67 indexed citations
10.
Covvey, Jordan R., Stuart McTaggart, & Iain Bishop. (2010). Management of medication use in Scotland. American Journal of Health-System Pharmacy. 67(16). 1378–1382. 1 indexed citations
11.
Godman, Brian, William H. Shrank, Björn Wettermark, et al.. (2010). Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?. Pharmaceuticals. 3(8). 2470–2494. 70 indexed citations
12.
McTaggart, Stuart, Iain Bishop, & Marion Bennie. (2009). Comparing medicines use. British Journal of Clinical Pharmacology. 1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina Garuolienė Breakdown of academic impact, for papers by Colleen Bush Breakdown of academic impact, for papers by Jurij Fürst Breakdown of academic impact, for papers by Inês Teixeira Breakdown of academic impact, for papers by Cynthia Reilly Breakdown of academic impact, for papers by Gin Nie Chua Breakdown of academic impact, for papers by Caijun Yang Breakdown of academic impact, for papers by Alvaro San-Juan-Rodriguez Breakdown of academic impact, for papers by Christine Huttin Breakdown of academic impact, for papers by Sundus Shukar
Rankless by CCL
2026